Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil-dexmedetomidine for Pediatric Surgery
NCT02799589Phase 4Withdrawn
- Start
- Jul 2016
- Primary completion
- Aug 2017
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of remifentanil, dexmedetomidine in inguinal hernia, hydrocele, cryptorchidism, hypospadias. Planned start Jul 2016; status: withdrawn.
02
Drugs
remifentanildexmedetomidine
03
Conditions
inguinal herniahydrocelecryptorchidismhypospadias
Beyond the preview
Go deeper on NCT02799589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02799589.